Membership Drive
MAPS still needs to grow. I'd like to see MAPS reach a membership level of 1,500 by the end of 1996. With that level of membership, the cost of operating MAPS will be fully covered by standard membership contributions. Special donations would not be required to make ends meet and could be used entirely for research projects. In order to work toward this goal, MAPS has approached the Drug Policy Foundation (DPF) seeking permission to enclose a membership solicitation with the DPF's mailing of its newsletter to its 20,000 members. Final approval waits upon the completion of the brochure and its review by DPF staff.
While attending a recent Board meeting of the Heffter Research Institute (HRI), I learned that HRI was interested in sending its own brochure to the DPF members and had also contacted DPF. As a result, MAPS and HRI decided to try to collaborate on the design of a brochure that would be about both organizations. The brochure will emphasize our common interest in supporting psychedelic research and will highlight our differing strategies. MAPS seeks to support psychedelic researchers wherever they happen to work while HRI seeks to establish an independent institution devoted to all aspects of psychedelic research. I'm hopeful that 1996 will bring about the design and distribution of a combined MAPS/ HRI membership solicitation.
Milestones
October 1995
Dr. Krupitsky completes an investigation of the underlying psychological mechanisms of ketamine psychedelic therapy (KPT) in the treatment of alcohol dependence.November 27, 1995
Dr. Grob administers MDMA to the last subject in the Phase 1 MDMA safety study.December 1995
MAPS donates $25,000 to the Phase 1 Ibogaine Research of Drs. Sanchez-Ramos and Deborah Mash.January 1996
MAPS donates $6,000 for the pharmacokinetics portion of the Phase 1 MDMA Safety Study. This represents the final expenditure needed for this study.